11. Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. (March 2016) Authors: Strasser-Weippl, Kathrin; Horick, Nora; Smith, Ian E.; O'Shaughnessy, Joyce; Ejlertsen, Bent; Boyle, Frances; Buzdar, Aman U.; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; Piccart-Gebhart, Martine; Pritchard, Kathleen I.; Lindquist, Deborah; Rappold, Erica; Finkelstein, Dia... Journal: European journal of cancer Issue: Volume 56(2016) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. (March 2016) Authors: Strasser-Weippl, Kathrin; Horick, Nora; Smith, Ian E.; O'Shaughnessy, Joyce; Ejlertsen, Bent; Boyle, Frances; Buzdar, Aman U.; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; Piccart-Gebhart, Martine; Pritchard, Kathleen I.; Lindquist, Deborah; Rappold, Erica; Finkelstein, Dia... Journal: European journal of cancer Issue: Volume 56(2016) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. In Reply. (4th December 2017) Authors: Gradishar, William; Brown, Krystal; Mundt, Erin; Manley, Susan Journal: Oncologist Issue: Volume 22:Number 12(2017) Page Start: 1540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. Issue 1 (December 2015) Authors: Strasser-Weippl, Kathrin; Horick, Nora; Smith, Ian; O'Shaughnessy, Joyce; Ejlertsen, Bent; Boyle, Frances; Buzdar, Aman; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; Piccart-Gebhart, Martine; Pritchard, Kathleen; Lindquist, Deborah; Rappold, Erica; Finkelstein, Dianne; Goss... Journal: Breast cancer research Issue: Volume 17:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY. (12th August 2019) Authors: Kumthekar, Priya; Lassman, Andrew B; Lin, Nancy; Grimm, Sean; Gradishar, William; Pentsova, Elena; Jeyapalan, Suriya; Groves, Morris; Melisko, Melissa; Raizer, Jeffrey Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer. Issue 1 (13th February 2020) Authors: Shah, Ami N; Flaum, Lisa; Helenowski, Irene; Santa-Maria, Cesar A; Jain, Sarika; Rademaker, Alfred; Nelson, Valerie; Tsarwhas, Dean; Cristofanilli, Massimo; Gradishar, William Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer. (20th February 2017) Authors: Vahdat, Linda T.; Layman, Rachel; Yardley, Denise A.; Gradishar, William; Salkeni, Mohamad A.; Joy, Anil Abraham; Garcia, Agustin A.; Ward, Patrick; Khatcheressian, James; Sparano, Joseph; Rodriguez, Gladys; Tang, Shande; Gao, Ling; Dalal, Rita P.; Kauh, John; Miller, Kathy Journal: Oncologist Issue: Volume 22:Number 3(2017) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer. (March 2017) Authors: Vahdat, Linda T.; Layman, Rachel; Yardley, Denise A.; Gradishar, William; Salkeni, Mohamad A.; Abraham Joy, Anil; Garcia, Agustin A.; Ward, Patrick; Khatcheressian, James; Sparano, Joseph; Rodriguez, Gladys; Tang, Shande; Gao, Ling; Dalal, Rita P.; Kauh, John; Miller, Kathy Journal: Oncologist Issue: Volume 22:Number 3(2017) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Risk factors for the development of paclitaxel‐induced neuropathy in breast cancer patients. Issue 2 (11th May 2018) Authors: Robertson, Jetter; Raizer, Jeffrey; Hodges, James S.; Gradishar, William; Allen, Jeffrey A. Journal: Journal of the peripheral nervous system Issue: Volume 23:Issue 2(2018) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examination. Issue 3 (6th October 2021) Authors: Auster‐Gussman, Lisa A.; Gavin, Kara L.; Siddique, Juned; Welch, Whitney A.; Solk, Payton; Whitaker, Madelyn; Cullather, Erin; Fanning, Jason; Maria, Cesar Santa; Gradishar, William; Khan, Seema; Kulkarni, Swati; Phillips, Siobhan M. Journal: Psycho-oncology Issue: Volume 31:Issue 3(2022) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗